Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; Arauz, G.; Curley, T.; Tse, K.; Halabi, S.; Scher, H. I.; Kelly, W. K. |
| Abstract Title: | Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 289s |
| Language: | English |
| ACCESSION: | WOS:000404711501069 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS5093 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS5093 -- Source: Wos |
